American Total Revenue vs Capex To Revenue Analysis

AMS Stock

USD 3.22 0.08 2.55%

American Shared financial indicator trend analysis is way more than just evaluating American Shared Hospital prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether American Shared Hospital is a good investment. Please check the relationship between American Shared Total Revenue and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Shared Hospital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Total Revenue vs Capex To Revenue

Total Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of American Shared Hospital Total Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have no relationship.

The correlation between American Shared's Total Revenue and Capex To Revenue is 0.05. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of American Shared Hospital, assuming nothing else is changed. The correlation between historical values of American Shared's Total Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of American Shared Hospital are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Total Revenue i.e., American Shared's Total Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.05

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Total Revenue

Total revenue comprises all receipts American Shared Hospital generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from American Shared's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into American Shared Hospital current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Shared Hospital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, American Shared's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.26 in 2024, whereas Selling General Administrative is likely to drop slightly above 4 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	739K	806K	1.1M	1.1M
Depreciation And Amortization	5.3M	5.1M	5.2M	6.6M

Interest Expense Depreciation And Amortization

American Shared fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Inventory	Intangible Assets	Accounts Payable	Current Deferred Revenue	Common Stock Total Equity
Total Assets		0.89	-0.24	0.62	0.54	0.93	0.77	0.76	-0.26	0.95	-0.02	-0.26	0.39	0.25	0.87	0.29	-0.32	0.92	0.36	0.28	0.62	0.38	-0.76	-0.75	0.79	-0.66
Short Long Term Debt Total	0.89		-0.12	0.53	0.16	0.81	0.89	0.58	-0.37	0.87	0.24	-0.37	0.02	-0.2	0.97	0.31	-0.45	0.99	0.13	0.16	0.64	0.51	-0.41	-0.41	0.87	-0.85
Other Current Liab	-0.24	-0.12		-0.35	-0.54	-0.48	-0.32	-0.32	0.47	-0.38	0.25	0.47	0.01	-0.15	-0.05	0.35	-0.21	-0.13	0.09	0.34	-0.57	-0.18	0.21	0.18	-0.45	-0.1
Total Current Liabilities	0.62	0.53	-0.35		0.28	0.55	0.47	0.35	-0.17	0.59	0.15	-0.17	0.12	0.18	0.34	0.01	-0.03	0.56	0.03	0.14	0.89	0.45	-0.5	-0.42	0.5	-0.2
Total Stockholder Equity	0.54	0.16	-0.54	0.28		0.62	0.3	0.7	-0.27	0.55	-0.6	-0.27	0.76	0.72	0.19	-0.07	0.13	0.24	0.44	0.11	0.23	-0.06	-0.73	-0.69	0.35	-0.02
Property Plant And Equipment Net	0.93	0.81	-0.48	0.55	0.62		0.82	0.81	-0.51	0.98	-0.17	-0.51	0.38	0.18	0.78	0.16	-0.26	0.83	0.12	-0.03	0.67	0.28	-0.66	-0.63	0.86	-0.64
Net Debt	0.77	0.89	-0.32	0.47	0.3	0.82		0.62	-0.73	0.85	0.07	-0.73	0.03	-0.24	0.85	0.08	-0.45	0.87	-0.06	-0.08	0.67	0.51	-0.27	-0.23	0.97	-0.84
Retained Earnings	0.76	0.58	-0.32	0.35	0.7	0.81	0.62		-0.44	0.78	-0.58	-0.44	0.67	0.21	0.58	0.15	-0.21	0.6	0.13	0.06	0.45	0.17	-0.52	-0.49	0.59	-0.44
Cash	-0.26	-0.37	0.47	-0.17	-0.27	-0.51	-0.73	-0.44		-0.47	0.25	1.0	-0.04	0.33	-0.32	0.08	0.17	-0.32	0.51	0.5	-0.47	-0.19	-0.13	-0.22	-0.7	0.52
Non Current Assets Total	0.95	0.87	-0.38	0.59	0.55	0.98	0.85	0.78	-0.47		-0.09	-0.47	0.34	0.11	0.84	0.15	-0.26	0.89	0.14	-0.03	0.68	0.28	-0.64	-0.6	0.87	-0.7
Non Currrent Assets Other	-0.02	0.24	0.25	0.15	-0.6	-0.17	0.07	-0.58	0.25	-0.09		0.25	-0.7	-0.35	0.21	0.1	-0.16	0.22	0.06	0.16	0.07	0.27	0.14	0.12	0.1	-0.18
Cash And Short Term Investments	-0.26	-0.37	0.47	-0.17	-0.27	-0.51	-0.73	-0.44	1.0	-0.47	0.25		-0.04	0.33	-0.32	0.08	0.17	-0.32	0.51	0.5	-0.47	-0.19	-0.13	-0.22	-0.7	0.52
Net Receivables	0.39	0.02	0.01	0.12	0.76	0.38	0.03	0.67	-0.04	0.34	-0.7	-0.04		0.66	0.06	0.2	0.09	0.08	0.32	0.22	-0.04	-0.27	-0.6	-0.56	0.0	0.02
Common Stock Shares Outstanding	0.25	-0.2	-0.15	0.18	0.72	0.18	-0.24	0.21	0.33	0.11	-0.35	0.33	0.66		-0.15	0.04	0.17	-0.08	0.66	0.46	-0.12	-0.19	-0.79	-0.78	-0.16	0.33
Non Current Liabilities Total	0.87	0.97	-0.05	0.34	0.19	0.78	0.85	0.58	-0.32	0.84	0.21	-0.32	0.06	-0.15		0.35	-0.47	0.97	0.25	0.22	0.45	0.42	-0.43	-0.45	0.84	-0.88
Other Current Assets	0.29	0.31	0.35	0.01	-0.07	0.16	0.08	0.15	0.08	0.15	0.1	0.08	0.2	0.04	0.35		0.13	0.31	0.16	0.46	-0.07	-0.16	-0.19	-0.22	0.13	-0.34
Other Stockholder Equity	-0.32	-0.45	-0.21	-0.03	0.13	-0.26	-0.45	-0.21	0.17	-0.26	-0.16	0.17	0.09	0.17	-0.47	0.13		-0.42	-0.05	-0.24	-0.09	-0.68	0.07	0.11	-0.33	0.48
Total Liab	0.92	0.99	-0.13	0.56	0.24	0.83	0.87	0.6	-0.32	0.89	0.22	-0.32	0.08	-0.08	0.97	0.31	-0.42		0.23	0.23	0.62	0.49	-0.51	-0.51	0.87	-0.83
Property Plant And Equipment Gross	0.36	0.13	0.09	0.03	0.44	0.12	-0.06	0.13	0.51	0.14	0.06	0.51	0.32	0.66	0.25	0.16	-0.05	0.23		0.77	-0.24	0.09	-0.64	-0.72	-0.01	0.08
Total Current Assets	0.28	0.16	0.34	0.14	0.11	-0.03	-0.08	0.06	0.5	-0.03	0.16	0.5	0.22	0.46	0.22	0.46	-0.24	0.23	0.77		-0.14	0.36	-0.44	-0.52	-0.09	0.02
Short Term Debt	0.62	0.64	-0.57	0.89	0.23	0.67	0.67	0.45	-0.47	0.68	0.07	-0.47	-0.04	-0.12	0.45	-0.07	-0.09	0.62	-0.24	-0.14		0.53	-0.29	-0.22	0.69	-0.36
Inventory	0.38	0.51	-0.18	0.45	-0.06	0.28	0.51	0.17	-0.19	0.28	0.27	-0.19	-0.27	-0.19	0.42	-0.16	-0.68	0.49	0.09	0.36	0.53		-0.09	-0.12	0.44	-0.32
Intangible Assets	-0.76	-0.41	0.21	-0.5	-0.73	-0.66	-0.27	-0.52	-0.13	-0.64	0.14	-0.13	-0.6	-0.79	-0.43	-0.19	0.07	-0.51	-0.64	-0.44	-0.29	-0.09		0.99	-0.34	0.2
Accounts Payable	-0.75	-0.41	0.18	-0.42	-0.69	-0.63	-0.23	-0.49	-0.22	-0.6	0.12	-0.22	-0.56	-0.78	-0.45	-0.22	0.11	-0.51	-0.72	-0.52	-0.22	-0.12	0.99		-0.31	0.18
Current Deferred Revenue	0.79	0.87	-0.45	0.5	0.35	0.86	0.97	0.59	-0.7	0.87	0.1	-0.7	0.0	-0.16	0.84	0.13	-0.33	0.87	-0.01	-0.09	0.69	0.44	-0.34	-0.31		-0.79
Common Stock Total Equity	-0.66	-0.85	-0.1	-0.2	-0.02	-0.64	-0.84	-0.44	0.52	-0.7	-0.18	0.52	0.02	0.33	-0.88	-0.34	0.48	-0.83	0.08	0.02	-0.36	-0.32	0.2	0.18	-0.79

Click cells to compare fundamentals

American Shared Account Relationship Matchups

American Shared fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.8M	43.7M	45.4M	44.0M	48.8M	56.0M
Short Long Term Debt Total	16.9M	14.4M	16.1M	14.3M	15.7M	24.7M
Other Current Liab	(284.3M)	3.9M	4.0M	3.1M	4.6M	4.8M
Total Current Liabilities	8.2M	12.4M	5.9M	5.2M	10.8M	10.8M
Total Stockholder Equity	31.8M	19.3M	24.2M	21.6M	22.6M	14.6M
Property Plant And Equipment Net	42.6M	31.3M	28.9M	23.8M	25.9M	37.6M
Net Debt	15.2M	10.4M	7.9M	1.9M	1.9M	1.8M
Retained Earnings	8.6M	1.5M	1.7M	3.0M	3.6M	3.8M
Cash	1.8M	4.0M	8.3M	12.5M	13.8M	14.5M
Non Current Assets Total	43.0M	32.8M	30.3M	25.2M	28.4M	41.5M
Non Currrent Assets Other	(2.5B)	137K	73K	(821.9M)	1.1M	1.2M
Cash And Short Term Investments	1.8M	4.0M	8.3M	12.5M	13.8M	14.5M
Net Receivables	7.1M	4.6M	4.8M	4.1M	4.8M	4.1M
Common Stock Shares Outstanding	5.9M	6.2M	6.1M	6.3M	6.4M	4.9M
Liabilities And Stockholders Equity	53.8M	43.7M	45.4M	44.0M	48.8M	56.0M
Non Current Liabilities Total	13.8M	7.6M	15.3M	17.2M	11.8M	18.5M
Other Current Assets	1.9M	2.3M	2M	2.1M	1.8M	2.0M
Other Stockholder Equity	12.5M	7.0M	7.4M	7.8M	8.2M	8.6M
Total Liab	22.0M	20.0M	21.2M	22.3M	22.6M	29.3M
Property Plant And Equipment Gross	41.5M	30.4M	74.6M	74.6M	81.3M	41.9M
Total Current Assets	10.7M	10.9M	15.1M	18.7M	20.5M	10.6M
Short Term Debt	6.0M	7.4M	1.5M	1.6M	4.6M	7.6M
Accounts Payable	557K	683K	318K	230K	315K	299.3K
Current Deferred Revenue	286M	210M	140M	70K	1.2M	1.2M
Other Assets	4.7M	1.0M	30.3M	87K	100.1K	95.0K
Long Term Debt	2.0M	3.4M	14.3M	12.2M	11.0M	12.4M
Property Plant Equipment	41.5M	19K	28.9M	23.8M	27.4M	42.5M
Net Tangible Assets	27.1M	21.7M	24.2M	21.6M	24.9M	24.4M
Noncontrolling Interest In Consolidated Entity	6.0M	5.9M	5.8M	4.4M	5.0M	5.7M
Retained Earnings Total Equity	6.9M	7.9M	8.6M	1.5M	1.3M	1.3M
Long Term Debt Total	10.1M	3.4M	14.3M	12.2M	11.0M	15.4M
Capital Surpluse	6.7M	7.0M	7.4M	7.8M	9.0M	6.8M
Capital Lease Obligations	8.2M	9.8M	728K	351K	57K	54.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for American Stock Analysis

When running American Shared's price analysis, check to measure American Shared's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy American Shared is operating at the current time. Most of American Shared's value examination focuses on studying past and present price action to predict the probability of American Shared's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move American Shared's price. Additionally, you may evaluate how the addition of American Shared to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC